BIOCURE: ESTABLISHMENT AND PURPOSE
BIOCURE: ESTABLISHMENT AND PURPOSE
BIOCURE: ESTABLISHMENT AND PURPOSE
As governments fell short of producing solutions for transforming people, private health organizations stepped in. Established in Germany in late 2034, BioCure Networks & Labs became one of the pioneering institutions in this field.
The company focused on tracking cases, creating transmission maps, and sharing the obtained data with global health authorities. At the same time, significant efforts were made for the psychological adaptation and integration of transformed individuals into society.
With its developed treatments contributing to the reduction of fatigue symptoms, BioCure rapidly grew to become one of the world's largest laboratory networks.
As governments fell short of producing solutions for transforming people, private health organizations stepped in. Established in Germany in late 2034, BioCure Networks & Labs became one of the pioneering institutions in this field.
The company focused on tracking cases, creating transmission maps, and sharing the obtained data with global health authorities. At the same time, significant efforts were made for the psychological adaptation and integration of transformed individuals into society.
With its developed treatments contributing to the reduction of fatigue symptoms, BioCure rapidly grew to become one of the world's largest laboratory networks.
As governments fell short of producing solutions for transforming people, private health organizations stepped in. Established in Germany in late 2034, BioCure Networks & Labs became one of the pioneering institutions in this field.
The company focused on tracking cases, creating transmission maps, and sharing the obtained data with global health authorities. At the same time, significant efforts were made for the psychological adaptation and integration of transformed individuals into society.
With its developed treatments contributing to the reduction of fatigue symptoms, BioCure rapidly grew to become one of the world's largest laboratory networks.
The mission of the BioCure Network was to quickly and effectively process the information of transforming people into health records, trace possible transmissions backwards to create a spread map, and organize the data obtained to share with both governments and other health organizations, taking a leading role in the search for solutions. The organization also filled an important gap in the health field by analyzing the psychological state of the weirds, providing the necessary orientations, and working to integrate them into society.
The mission of the BioCure Network was to quickly and effectively process the information of transforming people into health records, trace possible transmissions backwards to create a spread map, and organize the data obtained to share with both governments and other health organizations, taking a leading role in the search for solutions. The organization also filled an important gap in the health field by analyzing the psychological state of the weirds, providing the necessary orientations, and working to integrate them into society.
The mission of the BioCure Network was to quickly and effectively process the information of transforming people into health records, trace possible transmissions backwards to create a spread map, and organize the data obtained to share with both governments and other health organizations, taking a leading role in the search for solutions. The organization also filled an important gap in the health field by analyzing the psychological state of the weirds, providing the necessary orientations, and working to integrate them into society.
BioCure Labs focuses on biological therapies and innovative research, with volunteers providing blood and tissue samples. They developed two drugs in lab experiments to alleviate the fatigue of the Greys: the ChronoVitalizer injection, administered at a site near the navel, with critical timing; early use can lead to uncontrolled movements. The TempoStim pill is easier to use, taking effect in 30-40 minutes and enhancing endurance, but it carries a risk of addiction with long-term use. Both drugs aimed to rapidly reduce fatigue, but unexpected side effects could occur.
BioCure Labs focuses on biological therapies and innovative research, with volunteers providing blood and tissue samples. They developed two drugs in lab experiments to alleviate the fatigue of the Greys: the ChronoVitalizer injection, administered at a site near the navel, with critical timing; early use can lead to uncontrolled movements. The TempoStim pill is easier to use, taking effect in 30-40 minutes and enhancing endurance, but it carries a risk of addiction with long-term use. Both drugs aimed to rapidly reduce fatigue, but unexpected side effects could occur.
BioCure Labs focuses on biological therapies and innovative research, with volunteers providing blood and tissue samples. They developed two drugs in lab experiments to alleviate the fatigue of the Greys: the ChronoVitalizer injection, administered at a site near the navel, with critical timing; early use can lead to uncontrolled movements. The TempoStim pill is easier to use, taking effect in 30-40 minutes and enhancing endurance, but it carries a risk of addiction with long-term use. Both drugs aimed to rapidly reduce fatigue, but unexpected side effects could occur.
In June 2035, WHO had clarified the mode of transmission of the disease based on data collected from BioCure Networks&Labs and other health organizations: The most common transmission route was sexual intercourse. However, the riskiest period was the few weeks before the skin began to change color. During this period, because the skin was preparing for the change in color, it harbored a high amount of pathogens, creating a risk of transmission through contact. Therefore, sexual protection measures were ineffective during these times, and individuals unknowingly introduced the nanomorph into their bodies. After the transformation was complete, since there were no live pathogens left on the skin, transmission through contact did not occur.
In light of recent developments, WHO had concluded that the nanomorph was not harmful in the long term. In this case, it had announced that the existence of the Weirds as a distinct type needed to be accepted, but despite the objections of the Reds, the Weirds could not be removed from their patient status. However, it had also emphasized that this was not an epidemic.
In June 2035, WHO had clarified the mode of transmission of the disease based on data collected from BioCure Networks&Labs and other health organizations: The most common transmission route was sexual intercourse. However, the riskiest period was the few weeks before the skin began to change color. During this period, because the skin was preparing for the change in color, it harbored a high amount of pathogens, creating a risk of transmission through contact. Therefore, sexual protection measures were ineffective during these times, and individuals unknowingly introduced the nanomorph into their bodies. After the transformation was complete, since there were no live pathogens left on the skin, transmission through contact did not occur.
In light of recent developments, WHO had concluded that the nanomorph was not harmful in the long term. In this case, it had announced that the existence of the Weirds as a distinct type needed to be accepted, but despite the objections of the Reds, the Weirds could not be removed from their patient status. However, it had also emphasized that this was not an epidemic.
In June 2035, WHO had clarified the mode of transmission of the disease based on data collected from BioCure Networks&Labs and other health organizations: The most common transmission route was sexual intercourse. However, the riskiest period was the few weeks before the skin began to change color. During this period, because the skin was preparing for the change in color, it harbored a high amount of pathogens, creating a risk of transmission through contact. Therefore, sexual protection measures were ineffective during these times, and individuals unknowingly introduced the nanomorph into their bodies. After the transformation was complete, since there were no live pathogens left on the skin, transmission through contact did not occur.
In light of recent developments, WHO had concluded that the nanomorph was not harmful in the long term. In this case, it had announced that the existence of the Weirds as a distinct type needed to be accepted, but despite the objections of the Reds, the Weirds could not be removed from their patient status. However, it had also emphasized that this was not an epidemic.
